March 18, 2010 — A cardiac cryoablation catheter system designed for patients with paroxysmal atrial fibrillation (PAF) has completed premarket approval and is under review by the U.S. Food and Drug Administration (FDA).

March 23, 2010 - When imaging the brain, time is critical as vascular abnormalities can have a profound effect on patients’ lives if not diagnosed quickly. A new tool aims to help healthcare facilities diagnose disease with greater accuracy and speed when doing an magnetic resonance angiography study (MRA) on the brain.

March 23, 2010 – A femoral access delivery system to aid physicians placing inferior vena cava (IVC) filters was introduced last week at the Society of Interventional Radiology (SIR) Annual Scientific Meeting.

March 23, 2010 – The FDA granted approval for diltiazem hydrochloride extended-release tablets to treat hypertension, which is the generic equivalent to Biovail Laboratories International SRL's Cardizem LA product.

March 23, 2010 – At ACC last week Medtronic launched the Every Patient First health equity initiative, in partnership with healthcare providers, and professional societies, to reduce disparities in access to healthcare in the United States.

March 22, 2010 – The FDA’s Circulatory System Devices Panel last week unanimously recommended expanding the indication for cardiac resynchronization therapy defibrillators (CRT-Ds) to slow the progression of heart failure in patients with asymptomatic or mild heart failure (HF).

March 22, 2010 – Fractional flow reserve (FFR) technology from Volcano Corp. now integrates with the FFR modules of hemodynamic monitoring systems from GE, Siemens, McKesson, and Mennen.

March 22, 2010 – An FDA committee voted unanimously in favor of approval with conditions of a new pacemaker that is safe for use in magnetic resonance imaging (MRI) systems. MRI procedures are not recommended in the United States for patients who currently have implanted pacemakers.

March 22, 2010 – A pivotal clinical trial recently began to gain U.S. approval for a defibrillator system that does not have any leads in or on the heart. Additionally, no imaging equipment is required for placement of the system, since all of the components are positioned using anatomical landmarks.

March 19, 2010 – An experimental factor Xa inhibitor given to patients with non-valvular atrial fibrillation (AF) or atrial flutter and at least one risk factor for stroke, reduced the incidence of major and clinically relevant non-major (CRNM) bleeds compared to dose-adjusted warfarin.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now